Chemokine control of West Nile virus infection.
暂无分享,去创建一个
[1] Christopher J. Obara,et al. Chemokine Receptor Ccr2 Is Critical for Monocyte Accumulation and Survival in West Nile Virus Encephalitis , 2011, The Journal of Immunology.
[2] Ruth R. Montgomery,et al. A paradoxical role for neutrophils in the pathogenesis of West Nile virus. , 2010, The Journal of infectious diseases.
[3] D. Follmann,et al. CCR5 deficiency is a risk factor for early clinical manifestations of West Nile virus infection but not for viral transmission. , 2010, The Journal of infectious diseases.
[4] J. Wagner,et al. WEST NILE VIRUS : Epidemiology and Clinical Features of an Emerging Epidemic in the United States ∗ , 2010 .
[5] N. Van Rooijen,et al. Ly6c+ “inflammatory monocytes” are microglial precursors recruited in a pathogenic manner in West Nile virus encephalitis , 2008, The Journal of experimental medicine.
[6] M. Diamond,et al. CXCR4 antagonism increases T cell trafficking in the central nervous system and improves survival from West Nile virus encephalitis , 2008, Proceedings of the National Academy of Sciences.
[7] E. Pamer,et al. Additive Roles for MCP-1 and MCP-3 in CCR2-Mediated Recruitment of Inflammatory Monocytes during Listeria monocytogenes Infection1 , 2008, The Journal of Immunology.
[8] M. Diamond,et al. CXCR3 Mediates Region-Specific Antiviral T Cell Trafficking within the Central Nervous System during West Nile Virus Encephalitis1 , 2008, The Journal of Immunology.
[9] C. Jean,et al. Genetic deficiency of chemokine receptor CCR5 is a strong risk factor for symptomatic West Nile virus infection: a meta-analysis of 4 cohorts in the US epidemic. , 2008, The Journal of infectious diseases.
[10] M. Mack,et al. Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. , 2007, The Journal of clinical investigation.
[11] F. Tacke,et al. Migratory fate and differentiation of blood monocyte subsets. , 2006, Immunobiology.
[12] D. McDermott,et al. CCR5: no longer a "good for nothing" gene--chemokine control of West Nile virus infection. , 2006, Trends in immunology.
[13] E. Pamer,et al. Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2 , 2006, Nature Immunology.
[14] D. McDermott,et al. CCR5 deficiency increases risk of symptomatic West Nile virus infection , 2006, The Journal of experimental medicine.
[15] M. Diamond,et al. West Nile Virus from Infected Neurons T Cells Require Perforin to Clear + Cd8 , 2022 .
[16] D. Link,et al. G-CSF and AMD3100 mobilize monocytes into the blood that stimulate angiogenesis in vivo through a paracrine mechanism. , 2005, Blood.
[17] D. Link,et al. AMD 3100 mobilize monocytes into the blood that stimulate angiogenesis in vivo through a paracrine mechanism , 2006 .
[18] R. Cholera,et al. Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection , 2005, The Journal of experimental medicine.
[19] M. Diamond,et al. Neuronal CXCL10 Directs CD8+ T-Cell Recruitment and Control of West Nile Virus Encephalitis , 2005, Journal of Virology.
[20] D. Ben-Nathan,et al. West Nile virus neuroinvasion and encephalitis induced by macrophage depletion in mice , 2005, Archives of Virology.
[21] T. Mizutani,et al. Different chemokine expression in lethal and non‐lethal murine west nile virus infection , 2004, Journal of medical virology.
[22] M. McElrath,et al. Analysis of genetic polymorphisms in CCR5, CCR2, stromal cell-derived factor-1, RANTES, and dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin in seronegative individuals repeatedly exposed to HIV-1. , 2004, The Journal of infectious diseases.
[23] B. Wood,et al. Leukocytosis and Mobilization of CD34+ Hematopoietic Progenitor Cells by AMD3100, a CXCR4 Antagonist. , 2004, Supportive cancer therapy.
[24] J. Goedert,et al. MCP-1-MCP-3–Eotaxin gene cluster influences HIV-1 transmission , 2003, AIDS.
[25] R. Prayson,et al. The Neuropathology of West Nile Virus Meningoencephalitis , 2003 .
[26] R. Prayson,et al. The neuropathology of West Nile virus meningoencephalitis. A report of two cases and review of the literature. , 2003, American journal of clinical pathology.
[27] J. Flynn,et al. Mycobacterium tuberculosis in Chemokine Receptor 2-Deficient Mice: Influence of Dose on Disease Progression , 2002, Infection and Immunity.
[28] B. Rovin,et al. HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[29] J. Flynn,et al. Chemokine receptor 2 serves an early and essential role in resistance to Mycobacterium tuberculosis , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[30] R. Detels,et al. Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study , 2000, AIDS.
[31] M. Olszewski,et al. Leukocyte recruitment during pulmonary Cryptococcus neoformans infection. , 2000, Immunopharmacology.
[32] C. Ambrosi,et al. The pathology of human West Nile Virus infection. , 2000, Human pathology.
[33] W. Kuziel,et al. CCR2 Expression Determines T1 Versus T2 Polarization During Pulmonary Cryptococcus neoformans Infection1 , 2000, The Journal of Immunology.
[34] George Whyte-Melville,et al. Good for nothing , 1890 .